Sydney, Australia – 2 July 2025 – Southern Star Research has implemented Oracle Argus Safety as part of its ongoing investment program aimed at improving operational systems and supporting future growth. The new pharmacovigilance platform will allow the company to manage safety data more efficiently and meet global regulatory requirements with greater confidence.
With a strong focus on enhancing clinical capabilities, Southern Star Research has seen over 20% growth since January 2025, reflecting the company’s expanding role as a trusted partner to small and mid-sized biotechnology and pharmaceutical companies globally. The adoption of Oracle Argus Safety is a timely move to support this growth and ensure the company’s safety and medical monitoring systems remain reliable and compliant as study volumes increase.
“The integration of Oracle Argus Safety marks a key milestone in our clinical operations. It gives our safety team the tools and confidence to process adverse event data with greater accuracy, speed, and regulatory alignment, ultimately supporting better outcomes for our clients and their patients.”
Belinda Fricke
Head of Clinical Operations
Southern Star Research
“We are investing heavily in technology and talent to ensure that Southern Star Research continues to deliver premium-quality service with operational efficiency. Oracle Argus Safety is just one of many steps we are taking to scale responsibly and meet the growing demand from global biotech and pharma partners.”
Lloyd Prescott
Chief Executive Officer
Southern Star Research
Oracle Argus Safety is widely used by regulatory bodies and life sciences organisations to manage adverse event reports, track case histories, and support electronic submissions. It allows for more structured and accurate safety monitoring throughout the clinical trial process.
With extensive experience across therapeutic areas, Southern Star Research specializes in clinical trials from Phase I through Phase IV, including healthy volunteer studies. The company is known for its flexible, hands-on approach and deep understanding of the needs of emerging biotech firms.
Southern Star Research is a full-service CRO dedicated to navigating the complexities of bringing new medical products to market. With a legacy of excellence that began 14 years ago in Sydney, we have grown from a small, passionate team into a global network of experts committed to delivering high-quality services in medical writing, clinical monitoring, project management, biostatistics, data management, safety and medical monitoring, and quality assurance.
Southern Star Research has been recognized for its outstanding contributions to the field, winning prestigious awards such as the Great Place to Work in Australia in 2024 and 2025, APAC CRO of the Year 2025, and the Frost and Sullivan 2024 Asia-Pacific Competitive Strategy Leadership Award. Our international team continues to deliver innovative clinical trial solutions across diverse therapeutic areas, ensuring the success of every study we manage.
Oracle Argus Safety is a leading safety system used to manage drug safety reporting and pharmacovigilance across clinical development and post-marketing. The platform supports case intake, assessment, and global reporting to ensure compliance with international regulatory requirements.
Simi Barretto
Marketing and Digital Media Manager
Southern Star Research
Location: Australia
Email: media@southernstarresearch.com
Tel: +61283501918
L1, 1 Merriwa Street,
Gordon, NSW, 2072 Australia
Connect with us
Keep up to date with the latest news, updates and promotions
"*" indicates required fields
Each member of our Leadership Team boasts an average of 30 years experience. Our clients have access to an extraordinary group of Clinical Research professionals, whose experience covers Multinational Pharmaceutical companies, Biotechnology, Medical Device, CRO’s, research institutes, Universities, Industry Associations & Government Bodies. Together, we ensure that every aspect of your unique and novel drug study clinical trial is handled with scientific precision, care, and foresight.
Our team has all of the tools, knowledge and experience to solve almost any issue that may arise during the complex clinical trial process.
We recognize that each study is unique and different and there are nuances that need to be resolved proactively.
Our advisory board of top-tier specialists in multiple therapeutic areas engage in the early stages from protocol design in constructive discussions to anticipate challenges and enhance study efficiency throughout the study.